Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
13.66
-0.50 (-3.53%)
At close: Nov 20, 2026, 4:00 PM EST
13.70
+0.04 (0.29%)
After-hours: Nov 20, 2026, 7:30 PM EST
Mineralys Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $56 | Buy | Reiterates | $56 | +309.96% | Nov 9, 2026 |
| UBS | UBS | Hold Reiterates $29 → $19 | Hold | Reiterates | $29 → $19 | +39.09% | Nov 6, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $55 | Buy | Maintains | $55 | +302.64% | Nov 6, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 5, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 5, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $52 | Buy | Reiterates | $52 | +280.67% | Nov 5, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $52 | Buy | Reiterates | $52 | +280.67% | Aug 13, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $42 → $40 | Buy | Maintains | $42 → $40 | +192.83% | Aug 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.